For the latest updates on Gilead’s ongoing response to COVID-19, please click here.

Investor Relations

Contact Us

KiteKonnect®

Newsroom

Recent Press Releases

August 05, 2021
Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer
August 04, 2021
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland

Recent Company Statements

February 9, 2021
Kite Announces U.S. FDA Clearance of Investigational New Drug Application for KITE-222, an Anti-CLL-1 CAR T-Cell Therapy Candidate for Acute Myeloid Leukemia

Explore More

Media Inquiries

Gilead Newsroom